{"entity":{"id":"jsmo-jsco-guidelines","kind":"collection","name":"Japanese oncology guidelines (JSMO, JSCO and organ societies)","aka":[],"tldr":"The JSMO and JSCO guidelines are Japan's oncology guidelines, especially strong for gastric, oesophageal, liver and biliary cancers where Japanese trials set global standards (D2 gastrectomy, S-1, endoscopic resection), and for Japan's own approvals through PMDA.","summary":"Japanese organ societies publish some of the most detailed surgical and endoscopic guidelines in oncology (JGCA gastric cancer treatment guidelines, 6th edition 2021; Japan Esophageal Society; JSH hepatocellular carcinoma), reflecting trials such as JCOG9501, ACTS-GC, SPIRITS and JCOG1109. Drug availability differs (S-1, nedaplatin, TAS-102 origin), and PMDA approvals sometimes precede FDA (e.g. entrectinib, nivolumab for gastric cancer, cabozantinib-nivolumab). JSMO's clinical guidance on comprehensive genomic profiling underpins Japan's national reimbursement of CGP panels (2019).","asOf":"2026-09-08","links":[{"label":"JSMO","url":"https://www.jsmo.or.jp/en/"},{"label":"JGCA guidelines 2021 (Gastric Cancer)","url":"https://doi.org/10.1007/s10120-022-01331-8"}],"tags":["gap-fill","guidelines"],"related":["gastric","esophageal","hcc","cholangiocarcinoma","endoscopic-resection","cgp"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["jcog"],"institutions":["ncc-japan","jfcr"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["international-journal-of-clinical-oncology"],"dependsOn":[],"notes":[],"url":"https://www.jsmo.or.jp/en/","holds":"Japanese Society of Medical Oncology and Japan Society of Clinical Oncology guidelines; organ-specific societies (JGCA gastric, JSHBPS, JLCS lung, JBCS breast) publish detailed guidelines many translated into English; the JSMO/JSCO/JCA joint guideline on tumour-agnostic testing.","license":"Society terms","maintainer":"JSMO / JSCO"},"route":"/collections/jsmo-jsco-guidelines/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"},{"id":"esophageal","kind":"cancer","name":"Oesophageal cancer","route":"/cancers/esophageal/"}],"technology":[{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"},{"id":"endoscopic-resection","kind":"technology","name":"Endoscopic resection (EMR / ESD)","route":"/technologies/endoscopic-resection/"}],"company":[{"id":"jcog","kind":"company","name":"Japan Clinical Oncology Group (JCOG)","route":"/companies/jcog/"}],"institution":[{"id":"jfcr","kind":"institution","name":"Cancer Institute Hospital of JFCR","route":"/institutions/jfcr/"},{"id":"jsmo","kind":"institution","name":"Japanese Society of Medical Oncology","route":"/institutions/jsmo/"},{"id":"kyoto-university-hospital","kind":"institution","name":"Kyoto University Hospital","route":"/institutions/kyoto-university-hospital/"},{"id":"ncc-japan","kind":"institution","name":"National Cancer Center Hospital","route":"/institutions/ncc-japan/"}],"journal":[{"id":"international-journal-of-clinical-oncology","kind":"journal","name":"International journal of clinical oncology","route":"/journals/international-journal-of-clinical-oncology/"}]}}